Skip to content
Review Open access

The role of TGFB1 gene polymorphisms in the development of post-transplant complications and optimization of calcineurin inhibitor dosing in solid organ transplant recipients: a literature review

Sep 2026 · Russian Journal of Transplantology and Artificial Organs · 0 citations · 44 references

TL;DR

Current evidence regarding the role of TGFB1 gene polymorphisms in the development of post-transplant complications and their potential impact on calcineurin inhibitor dosing are analyzed to optimize immunosuppressive therapy in solid organ transplant recipients.

Abstract

Personalization of immunosuppressive therapy based on the recipient’s genetic profile remains a major challenge in transplant medicine, with important implications for reducing adverse effects associated with immunosuppressive drugs. Optimization of immunosuppressive regimens is largely focused on determining the appropriate dose of the calcineurin inhibitor tacrolimus (Tac), which serves as a key component of maintenance immunosuppressive therapy. A promising approach to this challenge is the identification of novel biomarkers associated with Тac response, among which transforming growth factor-β1 (TGF-β1), a key immunoregulatory cytokine, has attracted considerable attention. It has been established that the development of post-transplant complications, such as graft rejection, graft fibrosis, infectious complications, and nephrotoxicity, is associated with TGF-β1 expression levels. TGF-β1 production in the body is regulated by multiple factors, including genetic polymorphisms in the TGFB1 gene encoding this cytokine. This review analyzes current evidence regarding the role of TGFB1 gene polymorphisms in the development of post-transplant complications and their potential impact on calcineurin inhibitor dosing to optimize immunosuppressive therapy in solid organ transplant recipients.

Read PDF

Similar papers

Open access Sep 2026

The effect of immunosuppressive drugs based on calcineurin inhibitors on cell apoptosis and junctions between epithelial cells of rat’s jejunum

A reduction in epithelial cell height was observed, along with increased apoptosis of cells in the apical surface of the jejunal villi, as well as changes in the immunoexpression levels of intercellular tight and adhesion junction proteins.

K. Szumilas, A. Wilk, K. Misiakiewicz-Has et al. · 0 citations
Open access Aug 2026

Divergent roles of interleukin-12p40 and interleukin-18 in severe fibrosing chronic graft-versus-host-disease, immunity, and post-transplant outcomes.

Among 14 cytokines, IL-12p40 and IL-18 emerged as divergent signatures, both were elevated in patients who later developed severe fibrosing cGvHD, but their clinical associations differed markedly.

Salim Oulghazi, L. Alasfar, Mark E. Robinson et al. · 0 citations
Review Open access Oct 2026

Post-transplant diabetes mellitus: mechanisms of development, risk factors, diagnosis, treatment

The progressive increase in transplant activity is expected to increase the incidence of post-transplant complications, particularly post-transplant diabetes mellitus (PTDM). This review analyzes the epidemiology, risk factors, and key mechanisms for the development of this complication, such as immunosuppressive thera...

M. K. Vagabov, M. Shamkhalova, I. Dmitriev et al. · 0 citations
Open access Sep 2026

Calcineurin Inhibitor-Based Triple Immunosuppressive Therapy Induces Profibrotic Changes in the Jejunal Mucosa of Male Rats: A Digital Image Analysis of Collagen Fibers

Background/Objectives: Long-term immunosuppressive therapy administered to solid organ transplant recipients may induce adverse effects in various tissues, including the gastrointestinal tract. The aim of the present study was to evaluate the influence of prolonged treatment with calcineurin inhibitor (CNI)-based tripl...

K. Szumilas, A. Wilk, P. Szumilas et al. · 0 citations
Review Open access Sep 2026

Transformation of approaches to immunosuppressive therapy of IgA nephropathy: from systemic non‑specific to targeted drugs (Part 1)

IgA nephropathy (IgAN) is the most common primary chronic glomerulonephritis worldwide and a major cause of kidney failure requiring kidney replacement therapy. Current evidence indicates that its prognosis is considerably worse than previously assumed, while the proteinuria threshold associated with unfavorable outcom...

M. Zubkin, N. F. Frolova, V. I. Chervinko et al. · 0 citations
Sep 2026

A Retrospective Post-Marketing Surveillance Study on TGlobulin25®, the First Rabbit Anti-Thymocyte Globulin (r-ATG) Biosimilar Worldwide, as Induction Therapy in Adult Kidney Transplant Recipients

A post-marketing surveillance investigation comparing TGlobulin25 with the originator product regarding efficacy and safety in adult kidney transplant recipients found no statistically significant differences in major efficacy and safety outcomes.

M. Shafiekhani, Mohammad Amin Jafarzadeh, F. Shahabinezhad et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.